HUP9802419A2 - Antigén készítmények - Google Patents

Antigén készítmények

Info

Publication number
HUP9802419A2
HUP9802419A2 HU9802419A HUP9802419A HUP9802419A2 HU P9802419 A2 HUP9802419 A2 HU P9802419A2 HU 9802419 A HU9802419 A HU 9802419A HU P9802419 A HUP9802419 A HU P9802419A HU P9802419 A2 HUP9802419 A2 HU P9802419A2
Authority
HU
Hungary
Prior art keywords
production
prevention
treatment
eczema
medicinal preparations
Prior art date
Application number
HU9802419A
Other languages
English (en)
Inventor
Dieter Farnow
Ludmilla Ivanova
Joachim Karle
Igor D. Poliakov
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh. filed Critical Boehringer Ingelheim Vetmedica Gmbh.
Publication of HUP9802419A2 publication Critical patent/HUP9802419A2/hu
Publication of HUP9802419A3 publication Critical patent/HUP9802419A3/hu
Publication of HU224223B1 publication Critical patent/HU224223B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/165—Yeast isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/72—Candida
    • C12R2001/725—Candida albicans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/921—Candida
    • Y10S435/922—Candida albicans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány keratinőfil gőmbákból és élesztőkből előállítőttpőliszaccharidőkat és/vagy glikőpeptideket tartalmazó őlyan anyagőkravőnatkőzik, amelyek emlősöknél előfőrdűló különböző allergiásmegbetegedések megelőzésére és kezelésére szőlgálógyógyszerkészítmények előállítására alkalmasak. Ezek agyógyszerkészítmények példál alőpecia, ekcéma, neűrődermitis, tővábbálővak nyári ekcémájának megelőzésére és kezelésére szőlgálnak. A találmány tárgyát képezik az allergiaellenes anyagők előállításáhőzalkalmas gőmba- és élesztőfajők, valamint az előállítási eljárás is. ŕ
HU9802419A 1995-08-11 1996-08-09 Antigénkészítmények, előállításuk és alkalmazásaik HU224223B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9516461A GB2304347A (en) 1995-08-11 1995-08-11 Antigenic preparations
PCT/EP1996/003535 WO1997007232A1 (en) 1995-08-11 1996-08-09 Antigenic preparations

Publications (3)

Publication Number Publication Date
HUP9802419A2 true HUP9802419A2 (hu) 1999-02-01
HUP9802419A3 HUP9802419A3 (en) 1999-12-28
HU224223B1 HU224223B1 (hu) 2005-06-28

Family

ID=10779086

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802419A HU224223B1 (hu) 1995-08-11 1996-08-09 Antigénkészítmények, előállításuk és alkalmazásaik

Country Status (25)

Country Link
US (2) US6379678B1 (hu)
EP (1) EP0863991B1 (hu)
JP (3) JP4285768B2 (hu)
KR (1) KR100447926B1 (hu)
CN (1) CN1228450C (hu)
AR (1) AR008982A1 (hu)
AT (1) ATE253641T1 (hu)
AU (1) AU717731B2 (hu)
CA (1) CA2229203C (hu)
CO (1) CO4750671A1 (hu)
CZ (1) CZ294394B6 (hu)
DE (1) DE69630611T2 (hu)
DK (1) DK0863991T3 (hu)
ES (1) ES2206588T3 (hu)
GB (1) GB2304347A (hu)
HU (1) HU224223B1 (hu)
IL (1) IL123153A (hu)
MX (1) MX9801180A (hu)
NZ (1) NZ316062A (hu)
PL (1) PL186523B1 (hu)
PT (1) PT863991E (hu)
RU (1) RU2245721C2 (hu)
SK (1) SK282746B6 (hu)
WO (1) WO1997007232A1 (hu)
ZA (1) ZA966801B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
AU3547499A (en) * 1998-03-31 1999-10-18 Abbott Laboratories Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
CA2325063A1 (en) * 2000-10-27 2002-04-27 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Method for detecting antibodies to and antigens of fungal and yeast exposures
CN104147597A (zh) * 2002-12-16 2014-11-19 全球免疫股份有限公司 用于免疫治疗的基于酵母的疫苗
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
WO2010032139A1 (en) * 2008-09-17 2010-03-25 Hunter Immunology Limited Bacterial and fungal vaccines for the treatment of asthma
RU2660365C1 (ru) * 2015-11-20 2018-07-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Способ получения специфических антигенных препаратов из клинически значимых дрожжевых грибов
HRP20211604T1 (hr) * 2016-03-15 2022-01-21 Igor Polyakov Kompozicije za liječenje i prevenciju bolesti kopita i kandži
US11173193B2 (en) 2016-03-15 2021-11-16 Igor Polyakov Immunobiological products

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867555A (en) * 1972-11-29 1975-02-18 Anheuser Busch Manufacture of yeast protein isolate having a reduced nucleic acid content by an alkali process
FR2338287A1 (fr) * 1976-01-19 1977-08-12 Idemitsu Kosan Co Polysaccharide ayant la propriete de former un gel et procede microbiologique pour sa preparation
JPS536413A (en) * 1976-07-07 1978-01-20 Kureha Chem Ind Co Ltd Preparation of n-containing polysaccharides
NO153458C (no) * 1978-06-07 1986-03-26 Inst Experimentalnoi Veterinar Fremgangsm¨te for fremstilling av vaksine for profylakse o g behandling av ringorm hos pelsdyr og kaniner for¨rsaket av trichophyton mentagrophytes.
AU547928B2 (en) * 1981-11-03 1985-11-14 Sutka, K. Antigenic preparation from candida guilliermondii
GB8506373D0 (en) * 1985-03-12 1985-04-11 Axon Healthcare Ltd Antigens antibodies
GB8913737D0 (en) 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
WO1991015878A1 (de) 1990-04-09 1991-10-17 Adalbert Kopera Antennenanordnung
US5277904A (en) * 1990-10-26 1994-01-11 Pier Allan C Broad spectrum dermatophyte vaccine
RU2020959C1 (ru) 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
EP0714412A1 (en) 1993-08-19 1996-06-05 Minnesota Mining And Manufacturing Company Heparin functional affinity supports
AUPM473294A0 (en) * 1994-03-25 1994-04-21 Franklyn, Kathleen Mary Peptides for diagnostics and therapeutics
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine

Also Published As

Publication number Publication date
DE69630611T2 (de) 2004-06-03
ES2206588T3 (es) 2004-05-16
CN1228450C (zh) 2005-11-23
IL123153A0 (en) 1998-09-24
JP4286311B2 (ja) 2009-06-24
US7090857B2 (en) 2006-08-15
JP2008266352A (ja) 2008-11-06
NZ316062A (en) 1998-12-23
SK17798A3 (en) 1998-07-08
ZA966801B (en) 1997-03-14
KR19990036326A (ko) 1999-05-25
MX9801180A (es) 1998-04-30
IL123153A (en) 2002-05-23
KR100447926B1 (ko) 2004-11-09
AU717731B2 (en) 2000-03-30
ATE253641T1 (de) 2003-11-15
RU2245721C2 (ru) 2005-02-10
JPH11511019A (ja) 1999-09-28
HU224223B1 (hu) 2005-06-28
DE69630611D1 (de) 2003-12-11
DK0863991T3 (da) 2004-02-09
CZ294394B6 (cs) 2004-12-15
EP0863991A1 (en) 1998-09-16
CZ40098A3 (cs) 1998-07-15
EP0863991B1 (en) 2003-11-05
PL324975A1 (en) 1998-06-22
CA2229203C (en) 2011-12-13
CA2229203A1 (en) 1997-02-27
JP2008245658A (ja) 2008-10-16
AU6820796A (en) 1997-03-12
PT863991E (pt) 2004-01-30
JP4286312B2 (ja) 2009-06-24
HUP9802419A3 (en) 1999-12-28
PL186523B1 (pl) 2004-01-30
US6379678B1 (en) 2002-04-30
US20040071737A1 (en) 2004-04-15
SK282746B6 (sk) 2002-12-03
CO4750671A1 (es) 1999-03-31
CN1199426A (zh) 1998-11-18
GB9516461D0 (en) 1995-10-11
AR008982A1 (es) 2000-03-08
WO1997007232A1 (en) 1997-02-27
GB2304347A (en) 1997-03-19
JP4285768B2 (ja) 2009-06-24

Similar Documents

Publication Publication Date Title
BG102583A (en) Phenylthiazole derivatives having antiherpesviral properties
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
HUP9802234A2 (hu) Eljárás galantamin izolálására, valamint az ezt hatóanyagként tartalmazó gyógyszerkészítmények
HUP9802419A2 (hu) Antigén készítmények
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
CA2184262A1 (en) Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same
DE69431476T2 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
HUP9802121A2 (hu) Imidazolinszármazékok, eljárás előállításukra és e vegyületeket tartalmazó gyógyszerkészítmények
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
EP0728481A3 (de) Verwendun von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
PT600396E (pt) Vacinas contra protozoarios intestinais
DE866875T1 (de) Verfarhen zur herstellung von glycogen oder glycogenreichem hefeextrakt aus hefezellen und kosmetische zusammensetzungen, die diese enthalten
HUP0001644A2 (hu) Eljárás kitinázok előállítására
AU3808795A (en) Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal product and their intended use in anticancer treatments
ATE216251T1 (de) Myrteextrakt enthaltendes haarpflegemittel, verfahren zur herstellung und verwendung insbesondere für eine antischuppenbehandlung
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
AU1594897A (en) Solid instant-release forms of administration and process for producing the same
ATE42466T1 (de) Verwendung von saccharomyces hefen zur herstellung eines medikaments zur verhuetung oder behandlung von pseudomembrankolitis.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DE69003960D1 (de) Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten.
AU4747497A (en) Sordarin derivatives
SE9003311L (sv) Anvaendning av glykoproteiner, utvunna fraan gram (-) bakterier, foer tillverkning av kosmetiska eller dermatologiska kompositioner och kompositioner omfattande dessa glykoproteiner
BR9704615A (pt) formononetina de metal alcalino e processo de estimulação micorrizal

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050510